Vamil Divan
Stock Analyst at Guggenheim
(4.87)
# 336
Out of 4,712 analysts
995
Total ratings
62.2%
Success rate
16.2%
Average return
Main Sectors:
Stocks Rated by Vamil Divan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Reiterated: Buy | $146 → $170 | $147.53 | +15.23% | 52 | Sep 8, 2026 | |
| ELOX Eloxx Pharmaceuticals | Reiterated: Buy | $43 | $16.02 | +168.41% | 2 | Aug 23, 2026 | |
| STO: VICO Vicore Pharma Holding AB (publ) | Reiterated: Buy | kr 38.00 | kr 11.40 | +233.33% | 3 | Aug 21, 2026 | |
| CALC CalciMedica | Initiated Coverage: Buy | $9 | $2.30 | +292.16% | 1 | Aug 20, 2026 | |
| SVRA Savara | Reiterated: Buy | $11 | $5.42 | +103.14% | 11 | Aug 20, 2026 | |
| ASMB Assembly Biosciences | Reiterated: Buy | $43 | $32.87 | +30.82% | 13 | Aug 16, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $76 | $33.78 | +124.99% | 16 | Aug 14, 2026 | |
| VALN Valneva SE | Reiterated: Buy | $11 | $6.68 | +64.67% | 10 | Aug 13, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $37 → $25 | $5.12 | +388.28% | 9 | Aug 12, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $47 | $19.06 | +146.59% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $343 → $388 | $391.27 | -0.84% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $119 | $70.70 | +68.32% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 → $205 | $128.80 | +59.16% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $31 | $27.78 | +11.59% | 119 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $270 → $287 | $267.08 | +7.46% | 55 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $75 | $66.22 | +13.26% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $261 → $288 | $250.91 | +14.78% | 130 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $4.91 | -38.90% | 5 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.65 | +73.41% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.82 | +183.69% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $1.85 | n/a | 2 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.31 | n/a | 4 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €9.00 | €12.30 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1597 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $26 | $4.09 | n/a | 6 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 13 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $107.04 | n/a | 5 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1,124.21 | n/a | 95 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.71 | n/a | 7 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $210.63 | n/a | 15 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.57 | n/a | 31 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 | $27.68 | n/a | 20 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $45.40 | n/a | 72 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $2.91 | n/a | 11 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $107.39 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $738 | $807.65 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $41.81 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $141 | $42.85 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $17.06 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $265 | $521.12 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $155.14 | n/a | 30 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $23.84 | n/a | 4 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $33.45 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.07 | n/a | 3 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $36.85 | n/a | 55 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.22 | n/a | 2 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $55 | $64.41 | n/a | 45 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $27.43 | n/a | 10 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $83.56 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $13.33 | n/a | 6 | Aug 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $312 → $322 | $210.73 | n/a | 2 | Aug 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $0.293 | n/a | 1 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $35 → $30 | $3.19 | n/a | 6 | Feb 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 → $230 | $205.00 | n/a | 7 | Jan 28, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $145.65 | n/a | 1 | Apr 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $144.75 | n/a | 1 | Mar 5, 2013 |
Merck & Co.
Sep 8, 2026
Reiterated: Buy
Price Target: $146 → $170
Current: $147.53
Upside: +15.23%
Eloxx Pharmaceuticals
Aug 23, 2026
Reiterated: Buy
Price Target: $43
Current: $16.02
Upside: +168.41%
Vicore Pharma Holding AB (publ)
Aug 21, 2026
Reiterated: Buy
Price Target: kr 38.00
Current: kr 11.40
Upside: +233.33%
CalciMedica
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $2.30
Upside: +292.16%
Savara
Aug 20, 2026
Reiterated: Buy
Price Target: $11
Current: $5.42
Upside: +103.14%
Assembly Biosciences
Aug 16, 2026
Reiterated: Buy
Price Target: $43
Current: $32.87
Upside: +30.82%
Vera Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $76
Current: $33.78
Upside: +124.99%
Valneva SE
Aug 13, 2026
Reiterated: Buy
Price Target: $11
Current: $6.68
Upside: +64.67%
Unicycive Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $37 → $25
Current: $5.12
Upside: +388.28%
Jade Biosciences
Aug 10, 2026
Reiterated: Buy
Price Target: $47
Current: $19.06
Upside: +146.59%
Aug 7, 2026
Reiterated: Hold
Price Target: $343 → $388
Current: $391.27
Upside: -0.84%
Aug 7, 2026
Reiterated: Buy
Price Target: $124 → $119
Current: $70.70
Upside: +68.32%
Aug 6, 2026
Reiterated: Buy
Price Target: $207 → $205
Current: $128.80
Upside: +59.16%
Aug 6, 2026
Reiterated: Buy
Price Target: $35 → $31
Current: $27.78
Upside: +11.59%
Aug 5, 2026
Reiterated: Buy
Price Target: $270 → $287
Current: $267.08
Upside: +7.46%
Aug 5, 2026
Reiterated: Buy
Price Target: $65 → $75
Current: $66.22
Upside: +13.26%
Aug 3, 2026
Reiterated: Buy
Price Target: $261 → $288
Current: $250.91
Upside: +14.78%
Jul 1, 2026
Reiterated: Buy
Price Target: $5 → $3
Current: $4.91
Upside: -38.90%
Jun 25, 2026
Reiterated: Buy
Price Target: $15
Current: $8.65
Upside: +73.41%
Mar 20, 2026
Reiterated: Buy
Price Target: $8
Current: $2.82
Upside: +183.69%
Jul 13, 2025
Reiterated: Buy
Price Target: $6 → $7
Current: $1.85
Upside: n/a
May 29, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.31
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: €9.00
Current: €12.30
Upside: n/a
May 6, 2024
Reiterated: Hold
Price Target: n/a
Current: $0.1597
Upside: n/a
Jun 15, 2023
Reiterated: Buy
Price Target: $50 → $26
Current: $4.09
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $107.04
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $1,124.21
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $7.71
Upside: n/a
Jun 27, 2022
Reiterated: Buy
Price Target: $49
Current: $210.63
Upside: n/a
Jun 21, 2022
Reiterated: Buy
Price Target: $15
Current: $8.57
Upside: n/a
Jun 17, 2022
Rated: Hold
Price Target: $27
Current: $27.68
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $36
Current: $45.40
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $20 → $10
Current: $2.91
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $52
Current: $107.39
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $738
Current: $807.65
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $41.81
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $141
Current: $42.85
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $12
Current: $17.06
Upside: n/a
May 22, 2022
Initiated Coverage: Hold
Price Target: $265
Current: $521.12
Upside: n/a
May 4, 2022
Reiterated: Hold
Price Target: $95
Current: $155.14
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $58
Current: $23.84
Upside: n/a
May 7, 2021
Reiterated: Buy
Price Target: $37
Current: $33.45
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $4.07
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $36.85
Upside: n/a
Jul 10, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $1.22
Upside: n/a
May 29, 2019
Reiterated: Hold
Price Target: $59 → $55
Current: $64.41
Upside: n/a
Dec 13, 2018
Upgraded: Buy
Price Target: n/a
Current: $27.43
Upside: n/a
Nov 27, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $83.56
Upside: n/a
Aug 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $13.33
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $312 → $322
Current: $210.73
Upside: n/a
Oct 26, 2015
Rated: Buy
Price Target: $29
Current: $0.293
Upside: n/a
Feb 4, 2015
Downgraded: Sell
Price Target: $35 → $30
Current: $3.19
Upside: n/a
Jan 28, 2015
Reiterated: Buy
Price Target: $198 → $230
Current: $205.00
Upside: n/a
Apr 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $145.65
Upside: n/a
Mar 5, 2013
Initiated Coverage: Buy
Price Target: $48
Current: $144.75
Upside: n/a